Profiel
David Rhodes is the founder of ReNerve Ltd., a company founded in 2016.
He holds the title of Executive Director & Chief Scientific Officer at ReNerve Ltd. Dr. Rhodes also held former positions at Tali Digital Ltd. as Senior Vice President-Biology, Anteris Technologies Ltd. as Chief Scientific Officer from 2013 to 2016, and AdAlta Ltd. as Chief Operating Officer from 2016 to 2017.
Actieve functies van David Rhodes
| Bedrijven | Functie | Begin |
|---|---|---|
| RENERVE LIMITED | Oprichter | 16-09-2016 |
Eerdere bekende functies van David Rhodes
| Bedrijven | Functie | Einde |
|---|---|---|
| ADALTA LIMITED | Operationeel Directeur | 01-02-2017 |
Anteris Technologies Ltd.
Anteris Technologies Ltd. Medical SpecialtiesHealth Technology Engages in designing, developing and commercializing of medical devices to restore healthy heart function | Hoofd Techniek/Wetenschap/O&O | 01-11-2016 |
| TALI DIGITAL LIMITED | Corporate Officer/Principal | 18-06-2010 |
Opleiding van David Rhodes
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Tali Digital Ltd.
Tali Digital Ltd. Packaged SoftwareTechnology Services Discovers and develops anti-infective pharmaceutical medicines | Technology Services |
LaTrobe University
LaTrobe University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AdAlta Ltd.
AdAlta Ltd. BiotechnologyHealth Technology Discovers and develops i-body drugs to treat fibrotic diseases | Health Technology |
Anteris Technologies Ltd.
Anteris Technologies Ltd. Medical SpecialtiesHealth Technology Engages in designing, developing and commercializing of medical devices to restore healthy heart function | Health Technology |
Renerve Pty Ltd.
Renerve Pty Ltd. BiotechnologyHealth Technology Specializes in the development of novel products | Health Technology |
















